These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of left ventricular enlargement as a marker of early disease in familial dilated cardiomyopathy. Fatkin D, Yeoh T, Hayward CS, Benson V, Sheu A, Richmond Z, Feneley MP, Keogh AM, Macdonald PS. Circ Cardiovasc Genet; 2011 Aug 01; 4(4):342-8. PubMed ID: 21636824 [Abstract] [Full Text] [Related]
7. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Störk S, Boivin V, Horf R, Hein L, Lohse MJ, Angermann CE, Jahns R. Am Heart J; 2006 Oct 01; 152(4):697-704. PubMed ID: 16996841 [Abstract] [Full Text] [Related]
8. Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy. Miettinen KH, Eriksson S, Magga J, Tuomainen P, Kuusisto J, Vanninen EJ, Turpeinen A, Punnonen KR, Pettersson K, Peuhkurinen KJ. J Card Fail; 2008 Aug 01; 14(6):481-8. PubMed ID: 18672196 [Abstract] [Full Text] [Related]
9. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology. Skwarek M, Bilińska ZT, Mazurkiewicz Ł, Grzybowski J, Kruk M, Kurjata P, Piotrowski W, Ruzyłło W. Kardiol Pol; 2008 May 01; 66(5):515-22, discussion 523-4. PubMed ID: 18537059 [Abstract] [Full Text] [Related]
10. [The natural history of dilated cardiomyopathy: a review of the Heart Muscle Disease Registry of Trieste]. Di Lenarda A, Pinamonti B, Mestroni L, Salvi A, Sabbadini G, Gregori D, Perkan A, Zecchin M, Carniel E, Bussani R, Silvestri F, Morgera T, Camerini F, Sinagra G, Gruppo di Studio sulle Malattie del Miocardio. Ital Heart J Suppl; 2004 Apr 01; 5(4):253-66. PubMed ID: 15346692 [Abstract] [Full Text] [Related]
11. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. Baig MK, Goldman JH, Caforio AL, Coonar AS, Keeling PJ, McKenna WJ. J Am Coll Cardiol; 1998 Jan 01; 31(1):195-201. PubMed ID: 9426040 [Abstract] [Full Text] [Related]
12. Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy. Doesch AO, Mueller S, Nelles M, Konstandin M, Celik S, Frankenstein L, Goeser S, Kaya Z, Koch A, Zugck C, Katus HA. Basic Res Cardiol; 2011 Jan 01; 106(1):25-35. PubMed ID: 20957484 [Abstract] [Full Text] [Related]
15. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. Michels VV, Moll PP, Miller FA, Tajik AJ, Chu JS, Driscoll DJ, Burnett JC, Rodeheffer RJ, Chesebro JH, Tazelaar HD. N Engl J Med; 1992 Jan 09; 326(2):77-82. PubMed ID: 1727235 [Abstract] [Full Text] [Related]
17. Long-term outcome and risk stratification in dilated cardiolaminopathies. Pasotti M, Klersy C, Pilotto A, Marziliano N, Rapezzi C, Serio A, Mannarino S, Gambarin F, Favalli V, Grasso M, Agozzino M, Campana C, Gavazzi A, Febo O, Marini M, Landolina M, Mortara A, Piccolo G, Viganò M, Tavazzi L, Arbustini E. J Am Coll Cardiol; 2008 Oct 07; 52(15):1250-60. PubMed ID: 18926329 [Abstract] [Full Text] [Related]
20. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy. Doesch AO, Konstandin M, Celik S, Kristen A, Frankenstein L, Hardt S, Goeser S, Kaya Z, Katus HA, Dengler TJ. J Clin Apher; 2009 Oct 07; 24(4):141-9. PubMed ID: 19591221 [Abstract] [Full Text] [Related] Page: [Next] [New Search]